# FDA Inspection 1171686 - Xellia Pharmaceuticals Ltd. - December 08, 2021

Source: https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-ltd/2dafe0f8-7c76-4b6e-9e1a-910ed586f074
Source feed: FDA_Inspections

> FDA Inspection 1171686 for Xellia Pharmaceuticals Ltd. on December 08, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171686
- Company Name: Xellia Pharmaceuticals Ltd.
- Inspection Date: 2021-12-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 905986 - 2014-12-05](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-ltd/82c0ae70-c3ee-4e31-85fc-34956cab0872)
- [FDA Inspection 749888 - 2011-06-24](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-ltd/8ec4cf11-fd2c-4848-b8d7-fbcbbf715d0f)

Company: https://www.keypedia.com/companies/xellia-pharmaceuticals-ltd/fa083c19-dbb4-4e6a-9673-e846c25a5fc1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c